Results 81 to 90 of about 480,468 (239)

Multidistrict Outbreak of Marburg Virus Disease—Uganda, 2012 [PDF]

Journal of Infectious Diseases, 2015
In October 2012, a cluster of illnesses and deaths was reported in Uganda and was confirmed to be an outbreak of Marburg virus disease (MVD). Patients meeting the case criteria were interviewed using a standard investigation form, and blood specimens were tested for evidence of acute or recent Marburg virus infection by reverse transcription-polymerase
Ute Ströher, Edmund N. C. Newman, Kimberly A. Dodd, Shelley Campbell, Stuart T. Nichol, Luke Nyakarahuka, Ilana J. Schafer, Yap Boum, Barbara Knust, Estrella Lasry, Jane Ruth Aceng, Trevor Shoemaker, Hilde Declerck, Henry Kyobe Bosa, Joseph F. Wamala, Aridth Gibbons, Charles Okot, Alex Tumusiime, Issa Makumbi, Pierre E. Rollin, Anthony K. Mbonye, Stephen Balinandi   +21 more
openaire   +3 more sources

Ebola Haemorrhagic Fever in Africa: a Necessary Highlight [PDF]

, 2019
The purpose of this commentary is to re-evaluate the historic and scientific facts on Ebola haemorrhagic fever and the role of the International community, especially Economic Community of West African States (ECOWAS) in stemming the tide.
Adu-Gyamfi, S. (Samuel)
core   +3 more sources

Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment [PDF]

, 2007
The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the quality of clinical documentation. Surveillance and clinical records of 77
Antoine Tshomba, Benjamin Jeffs, Borchert M, Conrad JL, Daniel G. Bausch, Florimond Tshioko, Hilde Sleurs, Jean‐Jacques Muyembe‐Tamfum, Johnson ED, Maria D. Van Kerkhove, Martini GA, Matthias Borchert, Modeste Libande, Nikiforov VV, Pat Campbell, Patricia Pirard, Pierre E. Rollin, Robert Colebunders, Sabue Mulangu, Simon Mardel, Slenczka WG   +20 more
core   +2 more sources

Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. [PDF]

, 2008
The filoviruses, Marburg and Ebola, have the dubious distinction of being associated with some of the highest case-fatality rates of any known infectious disease-approaching 90% in many outbreaks.
A.G. Sprecher, Anon., Baize, Basler, Bausch, Bausch, Bausch, Bausch, Bausch, Bausch, Bausch, Bausch, Benjamin Jeffs, Bernard, Borchert, Bosio, Bosio, Boumandouki, Bray, Bray, Bray, Bray, Brummel-Ziedins, Bukreyev, Bwaka, CDC and WHO, Colebunders, Daddario-DiCaprio, Daniel G. Bausch, Dowell, Egbring, Emond, Enterlein, Feldmann, Formenty, Fourrier, Gear, Geisbert, Geisbert, Geisbert, Geisbert, Geisbert, Geisbert, Geisbert, Geisbert, Gibbs, Gupta, Hensley, Hensley, Hensley, Hewlett, Hewlett, Hoenen, Hotchkiss, Huggins, Jahrling, Jahrling, Jahrling, Jeffs, Johnson, Jones, Jones, Khan, Ksiazek, Kudoyarova-Zubavichene, Larkin, Leroy, Leroy, Mahanty, Mahanty, Martin, Martini, Martini, Monath, Mupapa, Mupapa, Nikiforov, Oswald, Parrino, Pattyn, Paul Boumandouki, Peters, Peterson, Peterson, Pourrut, Reid, Rivers, Roberts, Rollin, Sanchez, Schnittler, Schuler, Smith, Spurgers, Stille, Sullivan, Sullivan, Swanepoel, Takada, Todorovitch, Towner, Warfield, Warfield, Warfield, Wilson, Zaki   +105 more
core   +2 more sources

Experimental Vaccines for Prevention of Marburg Hemorrhagic Fever and Animal Models for Studying Pathogenesis

Проблемы особо опасных инфекций, 2018
Marburg fever is an acute natural-focal disease characterized by severe course, hemorrhagic syndrome, high level of contagiousness and lethality. The causative agent of the disease is the RNA-containing virus belonging to the family of filoviruses ...
N. V. Volkova, E. I. Kazachinskaya, D. N. Shcherbakov   +2 more
doaj   +1 more source

Selection of Filovirus Isolates for Vaccine Development Programs

Vaccines, 2021
The continuing outbreaks of ebola virus disease highlight the ongoing threat posed by filoviruses. Fortunately, licensed vaccines and therapeutics are now available for Zaire ebolavirus.
Daniel N. Wolfe, Carol L. Sabourin, Michael J. Merchlinsky, William C. Florence, Larry A. Wolfraim, Kimberly L. Taylor, Lucy A. Ward   +6 more
doaj   +1 more source

Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007 [PDF]

, 2011
Marburg hemorrhagic fever was detected among 4 miners in Ibanda District, Uganda, from June through September, 2007. Infection was likely acquired through exposure to bats or bat secretions in a mine in Kamwenge District, Uganda, and possibly human-to ...
Atek Kagirita, Bausch, Bausch, Ben Jeffs, Brian Amman, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Craig Manning, Edgar Kansiime, Eileen C. Farnon, Emmanuel Byaruhanga, F. Katunguka, Florimond Tschioko, Godfrey S. Bwire, Jennifer Adjemian, Jentes, Jonathan Towner, Jordan W. Tappero, Joseph F. Wamala, Julius J. Lutwama, Pierre E. Rollin, Pierre Formenty, Robert Downing, Sam Ahimbisibwe, Stuart T. Nichol, Swanepoel, Taylor, Timen, Towner, Towner, Wahl-Jensen, World Health Organization   +31 more
core   +2 more sources

Emergence of deadly viral haemorrhagic fever disease outbreaks in West Africa

Virulence, 2023
Recent viral hemorrhagic fever (VHF) disease outbreaks caused by Ebola virus (EBOV) and Marburg virus (MARV) in West Africa are unique and alarming.
Widaliz Vega-Rodriguez, Hinh Ly
doaj   +1 more source

Concurrent emergence of Marburg virus disease in Tanzania and Equatorial Guinea: a ticking time bomb

International Journal of Surgery: Global Health, 2023
Marburg virus disease (MVD) is a highly fatal viral hemorrhagic fever disease caused by a zoonotic virus, the Marburg virus, which is closely related to ebolaviruses within the family Filoviridae.
Lawal Lukman, Abdulateef J. Tawakalitu, Ashinze Patrick, Gbolahon A. Sodiq, J. M. Mubarak, Oluwakayode O. Oluwatobi, Oluwatomisin L. Abdulwahab, Majaliwa Kessy Mheta, T. Abdul-Rahman   +8 more
semanticscholar   +1 more source

Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008 [PDF]

, 2012
A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%).
A Grolla, A MacNeil, A Tuffs, AJ Georges, AM Casillas, B Jeffs, B Le Guenno, Benjamin Jeffs, BS Hewlett, DG Bausch, DG Bausch, DG Bausch, DG Bausch, DG Bausch, DH Smith, DL Heymann, E Mupere, ED Johnson, EM Leroy, EM Leroy, Esther Sterk, GA Martini, GA Martini, JL Conrad, Joseph Wamala, JS Gear, JS Towner, Julius Lutwama, K Kibadi, K Mupapa, K Mupapa, KJ Davis, M Borchert, M Bray, M Bray, MA Bwaka, Malcolm Gracie Semple, Maria D. Van Kerkhove, Matthias Borchert, ME Miranda, Michel Van Herp, MJ Bonnet, Natasha Howard, NK Jaax, P Formenty, P Formenty, P Francesconi, P Roddy, P Roddy, Paul Roddy, PE Rollin, Pedro Pablo Palma, PH Sureau, R Colebunders, R Ndambi, R Siegert, RC Baron, Robert Colebunders, RT Emond, S Becker, SF Dowell, SP Fisher-Hoch, SR Zaki, TH Roels, U Stroher, Y Kalongi, Zabulon Yoti   +66 more
core   +3 more sources